(Total Views: 327)
Posted On: 05/16/2020 9:47:43 PM
Post# of 36519
![Avatar](https://investorshangout.com/images/ProfileImages/2079059441_56748_Vaccine.jpg)
So did a little reading on NVAX and they got $179M from BARDA back in 2011 for their influenza vaccine development. In Sep 2016 the PH3 trial failed and they dropped 84% ($45B to $7B MktCap). No wonder they had to go to CEPI for more funding...
https://www.cnbc.com/2016/09/16/novavax-plung...grade.html
https://www.cnbc.com/2016/09/16/novavax-plung...grade.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)